相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。c-Myc inhibition prevents leukemia initiation in mice and impairs the growth of relapsed and induction failure pediatric T-ALL cells
Justine E. Roderick et al.
BLOOD (2014)
BET Bromodomain Inhibition of MYC-Amplified Medulloblastoma
Pratiti Bandopadhayay et al.
CLINICAL CANCER RESEARCH (2014)
Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia
Alejandro Gutierrez et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemia
A. Lonetti et al.
LEUKEMIA (2014)
Repression of BIM mediates survival signaling by MYC and AKT in high-risk T-cell acute lymphoblastic leukemia
C. Reynolds et al.
LEUKEMIA (2014)
An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia
Birgit Knoechel et al.
NATURE GENETICS (2014)
Oncogenic Mechanisms in Burkitt Lymphoma
Roland Schmitz et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
Discovery and Characterization of Super-Enhancer-Associated Dependencies in Diffuse Large B Cell Lymphoma
Bjoern Chapuy et al.
CANCER CELL (2013)
Complementary Genomic Screens Identify SERCA as a Therapeutic Target in NOTCH1 Mutated Cancer
Giovanni Roti et al.
CANCER CELL (2013)
Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
Jakob Loven et al.
CELL (2013)
The Ubiquitin Ligase FBXW7 Modulates Leukemia-Initiating Cell Activity by Regulating MYC Stability
Bryan King et al.
CELL (2013)
Protein trafficking abnormalities in Drosophila tissues with impaired activity of the ZIP7 zinc transporter Catsup
Casper Groth et al.
DEVELOPMENT (2013)
Small molecules intercept Notch signaling and the early secretory pathway
Andreas Kraemer et al.
NATURE CHEMICAL BIOLOGY (2013)
Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition
Alexandre Puissant et al.
CANCER DISCOVERY (2013)
BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia
Christopher J. Ott et al.
BLOOD (2012)
The Requirement for Cyclin D Function in Tumor Maintenance
Yoon Jong Choi et al.
CANCER CELL (2012)
Therapeutic Targeting of the Cyclin D3:CDK4/6 Complex in T Cell Leukemia
Catherine M. Sawai et al.
CANCER CELL (2012)
Targeting Nonclassical Oncogenes for Therapy in T-ALL
Prem S. Subramaniam et al.
CANCER CELL (2012)
Phase I, Dose-Escalation Study of BKM120, an Oral Pan-Class I PI3K Inhibitor, in Patients With Advanced Solid Tumors
Johanna C. Bendell et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Synergistic activity of rapamycin and dexamethasone in vitro and in vivo in acute lymphoblastic leukemia via cell-cycle arrest and apoptosis
Chong Zhang et al.
LEUKEMIA RESEARCH (2012)
Neutralization of the γ-secretase activity by monoclonal antibody against extracellular domain of nicastrin
I. Hayashi et al.
ONCOGENE (2012)
BET domain co-regulators in obesity, inflammation and cancer
Anna C. Belkina et al.
NATURE REVIEWS CANCER (2012)
Notch is oncogenic dominant in T-cell acute lymphoblastic leukemia
Renee M. Demarest et al.
BLOOD (2011)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
Bromodomains as therapeutic targets
Susanne Muller et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2011)
Notch1 loss of heterozygosity causes vascular tumors and lethal hemorrhage in mice
Zhenyi Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Johannes Zuber et al.
NATURE (2011)
A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia
Apostolos Klinakis et al.
NATURE (2011)
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
Xose S. Puente et al.
NATURE (2011)
Analysis of the coding genome of diffuse large B-cell lymphoma
Laura Pasqualucci et al.
NATURE GENETICS (2011)
Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia
Priscila P. Zenatti et al.
NATURE GENETICS (2011)
Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1
Nishant Agrawal et al.
SCIENCE (2011)
The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
Nicolas Stransky et al.
SCIENCE (2011)
Therapeutic promise and challenges of targeting DLL4/NOTCH1
Minhong Yan
VASCULAR CELL (2011)
Dll4-Notch signaling as a therapeutic target in tumor angiogenesis
Frank Kuhnert et al.
VASCULAR CELL (2011)
Activity of the Novel Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235 against T-Cell Acute Lymphoblastic Leukemia
Francesca Chiarini et al.
CANCER RESEARCH (2010)
mTOR and cancer: many loops in one pathway
Alejo Efeyan et al.
CURRENT OPINION IN CELL BIOLOGY (2010)
Rapamycin sensitizes T-ALL cells to dexamethasone-induced apoptosis
Ling Gu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Evaluation of Selective gamma-Secretase Inhibitor PF-03084014 for Its Antitumor Efficacy and Gastrointestinal Safety to Guide Optimal Clinical Trial Design
Ping Wei et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Therapeutic antibody targeting of individual Notch receptors
Yan Wu et al.
NATURE (2010)
Selective inhibition of BET bromodomains
Panagis Filippakopoulos et al.
NATURE (2010)
Characterization of Notch1 Antibodies That Inhibit Signaling of Both Normal and Mutated Notch1 Receptors
Miguel Aste-Amezaga et al.
PLOS ONE (2010)
High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia
Alejandro Gutierrez et al.
BLOOD (2009)
Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignancies
David T. Teachey et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation
Mauro Di Ianni et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
DLL4 Blockade Inhibits Tumor Growth and Reduces Tumor-Initiating Cell Frequency
Timothy Hoey et al.
CELL STEM CELL (2009)
Targeting the mTOR Signaling Network for Cancer Therapy
Funda Meric-Bernstam et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Increased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3K/mTOR inhibition
Madlaina Breuleux et al.
MOLECULAR CANCER THERAPEUTICS (2009)
NOTCH inhibition and glucocorticoid therapy in T-cell acute lymphoblastic leukemia
P. J. Real et al.
LEUKEMIA (2009)
Direct inhibition of the NOTCH transcription factor complex
Raymond E. Moellering et al.
NATURE (2009)
gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia
Pedro J. Real et al.
NATURE MEDICINE (2009)
NOTCH1 extracellular juxtamembrane expansion mutations in T-ALL
Maria Luisa Sulis et al.
BLOOD (2008)
A Notch1 ectodomain construct inhibits endothelial Notch signaling, tumor growth, and angiogenesis
Yasuhiro Funahashi et al.
CANCER RESEARCH (2008)
The role of the PTEN/AKT pathway in NOTCH1-induced leukemia
Teresa Palomero et al.
CELL CYCLE (2008)
In vitro validation of γ-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia
Kim De Keersmaecker et al.
HAEMATOLOGICA (2008)
Class IPI3K in oncogenic cellular transformation
L. Zhao et al.
ONCOGENE (2008)
PI3K pathway alterations in cancer: variations on a theme
T. L. Yuan et al.
ONCOGENE (2008)
Mammalian target of rapamycin (mTOR) inhibition activates phosphatidylinositol 3-kinase/Akt by up-regulating insulin-like growth factor-1 receptor signaling in acute myeloid leukemia: rationale for therapeutic inhibition of both pathways
Jerome Tamburini et al.
BLOOD (2008)
Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia
Teresa Palomero et al.
NATURE MEDICINE (2007)
Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia
Steven M. Chan et al.
BLOOD (2007)
Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis
Irene Noguera-Troise et al.
NATURE (2006)
Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis
John Ridgway et al.
NATURE (2006)
Essential role for cyclin D3 in granulocyte colony-stimulating factor-driven expansion of neutrophil granulocytes
Ewa Sicinska et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance
Guo Wei et al.
CANCER CELL (2006)
c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma
Andrew P. Weng et al.
GENES & DEVELOPMENT (2006)
CUTLL1, a novel human T-cell lymphoma cell line with t(7;9) rearrangement, aberrant NOTCH1 activation and high sensitivity to γ-secretase inhibitors
T. Palomero et al.
LEUKEMIA (2006)
Leukemia-associated mutations within the NOTCH1 heterodimerization domain fall into at least two distinct mechanistic classes
Michael J. Malecki et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia
C Grabher et al.
NATURE REVIEWS CANCER (2006)
TOR signaling in growth and metabolism
S Wullschleger et al.
CELL (2006)
TOR signaling in growth and metabolism
Stephan Wullschleger et al.
CELL (2006)
Requirement for CDK4 kinase function in breast cancer
QY Yu et al.
CANCER CELL (2006)
Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis
MW Landis et al.
CANCER CELL (2006)
Gene expression-based high-throughput screening (GE-HTS) and application to leukemia differentiation (vol 36, pg 257, 2004)
K Stegmaier et al.
NATURE GENETICS (2004)
Notch signaling in T- and B-cell development
F Radtke et al.
CURRENT OPINION IN IMMUNOLOGY (2004)
Mouse development and cell proliferation in the absence of D-cyclins
K Kozar et al.
CELL (2004)
Mammalian cells cycle without the D-type cyclin-elependent kinases Cdk4 and Cdk6
M Malumbres et al.
CELL (2004)
Living with or without cyclins and cyclin-dependent kinases
CJ Sherr et al.
GENES & DEVELOPMENT (2004)
Molecular basis of mantle cell lymphoma
F Bertoni et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Modulation of notch processing by γ-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation
J Milano et al.
TOXICOLOGICAL SCIENCES (2004)
Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia
AP Weng et al.
SCIENCE (2004)
Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition of notch signaling
AP Weng et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control
R Loewith et al.
MOLECULAR CELL (2002)
Suppression of Neu-induced mammary tumor growth in cyclin D1 deficient mice is compensated for by cyclin E
DB Bowe et al.
ONCOGENE (2002)
BRD4 bromodomain gene rearrangement in aggressive carcinoma with translocation t(15;19)
CA French et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Specific protection against breast cancers by cyclin D1 ablation
QY Yu et al.
NATURE (2001)
Essential roles for ankyrin repeat and transactivation domains in induction of T-cell leukemia by Notch1
JC Aster et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Notch signaling in T cell development
ML Deftos et al.
CURRENT OPINION IN IMMUNOLOGY (2000)
分享论文
